TerminatedPhase 3NCT00317629

Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundación Cardiovascular de Colombia
Principal Investigator
Patricio López-Jaramillo, MD, PhD
Cardiovascular Foundation of Colombia
Intervention
controlled nitric oxide releasing patch(drug)
Enrollment
178 enrolled
Eligibility
18-50 years · All sexes
Timeline
20062009

Study locations (1)

Collaborators

Universidad de Antioquia · The University of Akron · Universidad de Santander · Secretaria de Salud de Santander · Secretaria de Salud de Tolima

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00317629 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis

← Back to all trials